-
1.发明公开METHOD FOR TREATMENT OF DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE 审中-公开VERFAHREN ZUR BEHANDLUNG VON DEMYELINISIERENDER ERKRANKUNG DES ZENTRALEN NERVENSYSTEMS
公开(公告)号：EP3064215A1
公开(公告)日：2016-09-07
申请号：EP16155761.6
申请日：2003-10-16
申请人： Hunter, Samuel F.
发明人： Hunter, Samuel F.
CPC分类号： C07K14/535 , A61K38/193 , A61K38/21 , A61K2300/00
摘要： A method for treating demyelinating central nervous system diseases in a subject that comprises administering to the subject a composition comprising a therapeutically active amount of colony stimulating factor or CSF-like ligand. In a preferred embodiment of the present invention, the CSF is a GM - CSF. In a most preferred embodiment of the present invention, CSF is sargramostim.
摘要翻译： 一种用于治疗受试者的脱髓鞘性中枢神经系统疾病的方法，其包括向受试者施用包含治疗活性量的集落刺激因子或CSF-样配体的组合物。 在本发明的优选实施方案中，CSF是GM-CSF。 在本发明的最优选实施方案中，CSF是sargramostim。
-
2.发明公开METHOD FOR TREATMENT OF DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE USING GM-CSF 有权治理方法相关的DEMYLELIERUNG去中央神经系统疾病
公开(公告)号：EP1551444A2
公开(公告)日：2005-07-13
申请号：EP03776426.3
申请日：2003-10-16
申请人： Hunter, Samuel F.
发明人： Hunter, Samuel F.
IPC分类号： A61K38/19
CPC分类号： C07K14/535 , A61K38/193 , A61K38/21 , A61K2300/00
摘要： A method for treating demyelinating central nervous system diseases in a subject that comprises administering to the subject a composition comprising a therapeutically active amount of colony stimulating factor or CSF-like ligand. In a preferred embodiment of the present invention, the CSF is a GM - CSF. In a most preferred embodiment of the present invention, CSF is sargramostim.
摘要翻译： 一种用于在受试者中治疗脱髓鞘中枢神经系统疾病的方法做了包括施用给所述受试者的组合物，其包括集落的治疗活性量刺激因子或CSF样配体。 在本发明的一个优选实施例中，CSF是GM - CSF。 在本发明的最优选实施例，CSF是沙格司亭。
-
3.发明授权METHOD FOR TREATMENT OF DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE USING GM-CSF 有权用GM-CSF治疗中枢神经系统疾病的方法
公开(公告)号：EP1551444B1
公开(公告)日：2018-03-21
申请号：EP03776426.3
申请日：2003-10-16
申请人： Hunter, Samuel F.
发明人： Hunter, Samuel F.
IPC分类号： A61K38/19
CPC分类号： C07K14/535 , A61K38/193 , A61K38/21 , A61K2300/00
摘要： A method for treating demyelinating central nervous system diseases in a subject that comprises administering to the subject a composition comprising a therapeutically active amount of colony stimulating factor or CSF-like ligand. In a preferred embodiment of the present invention, the CSF is a GM - CSF. In a most preferred embodiment of the present invention, CSF is sargramostim.
-
-
搜索结果
3 条记录 (耗时 0.026 秒)
